Long‐acting muscarinic antagonists (LAMA) added to combination long‐acting beta2‐agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults …

KM Kew, K Dahri - Cochrane Database of Systematic Reviews, 2016 - cochranelibrary.com
Background Maintenance treatment with long‐acting beta 2‐agonists and inhaled corticosteroids
(LABA/ICS) can relieve asthma symptoms and reduce the frequency of exacerbations, …

[HTML][HTML] Evaluation of the use of inhaled medications by hospital inpatients with chronic obstructive pulmonary disease

J Batterink, K Dahri, A Aulakh… - The Canadian journal of …, 2012 - ncbi.nlm.nih.gov
Background The prevalence of chronic obstructive pulmonary disease (COPD) is increasing.
Patients with COPD are treated with a variety of inhaled medications. Previous studies …

Risk of bleeding with oral anticoagulants: an updated systematic review and performance analysis of clinical prediction rules

P Loewen, K Dahri - Annals of hematology, 2011 - Springer
This study aimed to determine whether progress in developing bleeding risk estimation
tools for patients on oral anticoagulant therapy has been made since 2006 when we last …

The risk of bleeding with warfarin: a systematic review and performance analysis of clinical prediction rules

K Dahri, P Loewen - Thrombosis and haemostasis, 2007 - thieme-connect.com
It was the objective of this article to qualitatively review and evaluate the clinical prediction
rules (CPRs) available for estimating bleeding risk in patients commencing warfarin therapy. …

The Pharmacist Guide to Implementing Pharmaceutical Care

K Dahri - The Canadian Journal of Hospital Pharmacy, 2019 - ncbi.nlm.nih.gov
The Pharmacist Guide to Implementing Pharmaceutical Care is intended as a comprehensive
reference for pharmacists who want to incorporate pharmaceutical care into their practice. …

Clinical pharmacokinetic monitoring of free valproic acid levels: A systematic review

K Lin, VFS Cao, C Au, K Dahri - Clinical Pharmacokinetics, 2022 - Springer
Background Current guidelines recommend therapeutic drug monitoring as a critical
component of valproic acid (VPA) therapy. Due to high protein binding, the active unbound (free) …

[HTML][HTML] Hospital pharmacists' perceptions and decision-making related to drug-drug interactions

H Bagri, K Dahri, M Legal - The Canadian Journal of Hospital …, 2019 - ncbi.nlm.nih.gov
Background Pharmacists often overlook drug interaction alerts because of limitations in
clinical decision support (CDS) software systems intended to detect evidence-based, clinically …

Efavirenz and nevirapine in HIV-1 infection: is there a role for clinical pharmacokinetic monitoring?

K Dahri, MHH Ensom - Clinical pharmacokinetics, 2007 - Springer
Nevirapine and efavirenz are nonnucleoside reverse transcriptase inhibitors used in
antiretroviral regimens to treat HIV infection. Therapeutic drug monitoring in patients on …

Evaluation of a symptom‐triggered protocol approach to the management of alcohol withdrawal syndrome in older adults

A Taheri, K Dahri, P Chan, M Shaw… - Journal of the …, 2014 - Wiley Online Library
Objectives To evaluate whether implementation of symptom‐triggered administration of a
benzodiazepine protocol reduces the severity (total cumulative dose), duration, and …

Incidence of clinically relevant medication errors in the era of electronically prepopulated medication reconciliation forms: a retrospective chart review

…, ME Wickham, S Lai, K Badke, K Dahri… - … Open Access Journal, 2017 - cmajopen.ca
Background: To reduce medication discrepancies (unintended differences between a patient's
outpatient and inpatient medication regimens), Canadian institutions have implemented …